• News
POSTED ON: 02 October 2020
Benefits hero banner
The Institute of Cancer Research, London, has again ranked among the top higher education institutions in the world for the impact of its research academically and commercially.

In this year’s 2020 U-Multirank report, The Institute of Cancer Research (ICR) was rated fourth in the world for the citation rate of scientific research, following institutions including Rockefeller University and MIT. And it also ranked fourth worldwide and top in the UK for top-cited research publications – those in a field’s most frequently cited 10 per cent of papers that year.

U-Multirank is an annual independent evaluation funded by the European Commission, and this year assessed data from 1,786 higher education institutions across the world.

Working with industry

Effective industry collaboration is at the heart of the ICR’s approach to drive benefits for patients, and its second-place ranking worldwide for the number of publications cited in patents highlights the impact the ICR has on innovative technologies and medicines throughout its research. 

Building on this success, the ICR and the London Borough of Sutton are working together to deliver The London Cancer Hub. Our vision is to create the world’s leading centre for cancer research, treatment and enterprise – a vibrant community of scientists, doctors and innovative companies, supported by state-of-the-art facilities.

The ICR also came eleventh worldwide for the proportion of its publications to feature an industry co-author, and in the top 20 institutions worldwide for its collaborations on a regional level – demonstrating its leadership in knowledge exchange and effective collaboration with neighbouring organisations.

In a separate report published by the UK patent office on Higher Education Institution patent filings, the ICR was ranked top for collaboration.

The UK Intellectual Property Office data showed the ICR filed some 92% of patent applications with an industry partner, compared to an average of about 60% across other UK Higher Education Institutions.

'At the pinnacle of research worldwide'

Dr Barbara Pittam, the ICR’s Director of Academic Services, said:
"Our rankings for 2020 show once again the ICR’s global reach and impact, and our success at tackling cancer through effective collaboration with academia and industry. I’m delighted to see us maintain our position at the pinnacle of research worldwide, as the number of universities participating in Multirank increases.”

Professor Paul Workman, Chief Executive of the ICR, said:
"I’m delighted that the dedication, excellence and innovation shown by ICR scientists is reflected in such a strong performance in these prestigious international rankings.
“Our high positions on citation rate and collaboration provide independent validation of the world-class quality of our research, and our effectiveness at delivering benefits for cancer patients through partnership and commercialisation.”
Back to top